Fundraising Fox

Oxford Performance Materials

South Windsor, US · Founded 2011 · Delaware corporation · 40 employees on LinkedIn

Oxford Performance Materials develops additive manufacturing (3D printing) technology and high-performance PEKK thermoplastics and coatings. Its products serve medical device applications, such as surgical implants via its OsteoFab platform, and industrial hardware markets through its OXFAB platform.

Advanced ManufacturingMedical DevicesNew Materials

Founders & leadership

Oxford Performance Materials was founded in 2011 by Scott DeFelice.

SD
Scott DeFeliceinFounder
JD
Jordan DeFeliceinExecutive
PM
Paul MartininExecutive
SZ
Severine ZygmontExecutive
AD
Anthony DeCarmineExecutive
CC
Christopher CodeanneinExecutive
JS
Jacqueline SymingtoninExecutive

Board

MF
Marc FasteauBoard director
RF
Robert FiondellaBoard director
AE
Amy EvansBoard director

Reported raises · per SEC filings

Form D private placements

$37.9M disclosed across 5 rounds · 2014–2025

▶$355KraisedJul 2025 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jordan DeFeliceExecutive Officer, Director
  • Marc FasteauDirector
  • Robert FiondellaDirector
  • Scott DeFeliceExecutive Officer, Director
  • Amy EvansDirector
Offering amount
$5M
Amount sold
$355K
Minimum investment
$25K
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.8MraisedFeb 2017 · 22 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc FasteauDirector
  • Lawrence VarholakExecutive Officer
  • Christopher CodeanneExecutive Officer, Director
  • Scott F DeFeliceExecutive Officer, Director
  • Robert FiondellaDirector
  • Severine ZygmontExecutive Officer, Director
  • Brett SchneiderDirector
Offering amount
$10.8M
Amount sold
$10.8M
Minimum investment
$1
Sales commissions
$350K
Placement agents
Barclays Capital Inc., NewCap Partners Inc.
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.8MraisedJun 2016 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence VarholakExecutive Officer
  • Scott F DeFeliceExecutive Officer, Director
  • Severine ZygmontExecutive Officer, Director
  • Christopher CodeanneExecutive Officer, Director
  • Brett SchneiderDirector
Offering amount
$15.8M
Amount sold
$15.8M
Minimum investment
$1
Sales commissions
$255K
Proceeds to insiders
$800K
Placement agents
NewCap Partners Inc.
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MraisedOct 2015 · 23 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul MartinExecutive Officer, Director
  • Severine ZygmontExecutive Officer, Director
  • Anthony DeCarmineExecutive Officer
  • Christopher CodeanneExecutive Officer
  • Jacqueline SymingtonExecutive Officer
  • Scott F DeFeliceExecutive Officer, Director
Offering amount
$5.4M
Amount sold
$5.4M
Minimum investment
$10K
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedDec 2014 · 37 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Severine ZygmontExecutive Officer, Director
  • Paul W MartinExecutive Officer, Director
  • Scott F DeFeliceExecutive Officer, Director
  • Anthony DeCarmineExecutive Officer
  • Jacqueline SymingtonExecutive Officer
Offering amount
$5.5M
Amount sold
$5.5M
Minimum investment
$25K
First sale
Feb 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Globus Medical7 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Sparta Biomedical6 shared keywordsSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

Companies competing with Oxford Performance Materials for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2019$202.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

OPM Secures Investment from Scalpel Ventures — Oxford Performance Materials, Inc.oxfordpm.com · Sep 2024Oxford Performance Materials – $10 Million second round financing from Hexcel – Feb 2017 | NewCap Partners Inc.newcap.com · Feb 2017

Frequently asked questions

What does Oxford Performance Materials do?
Oxford Performance Materials develops additive manufacturing (3D printing) technology and high-performance PEKK thermoplastics and coatings. Its products serve medical device applications, such as surgical implants via its OsteoFab platform, and industrial hardware markets through its OXFAB platform.
Who founded Oxford Performance Materials?
Oxford Performance Materials was founded by Scott DeFelice in 2011.
How much funding has Oxford Performance Materials raised?
Oxford Performance Materials has disclosed $37.9M raised across 5 rounds.
Where is Oxford Performance Materials headquartered?
Oxford Performance Materials is headquartered in South Windsor, US.